Patent · US Active

Genetically modified human cell with a corrected mutant sickle cell mutation

US10435677B2 · kind B2 · utility

4Cited by
56References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 16, 2015
Grant dateOct 8, 2019
Priority date—
Expiry dateSep 16, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2800/80
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure is in the field of genome engineering, particularly targeted modification of the genome of a hematopoietic stem cell.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.